Clinical trial
Metronomic Chemotherapy With Bevacizumab for Advanced Breast Cancer
NCT00083031 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metronomic Chemotherapy With Bevacizumab for Advanced Breast Cancer
- Lead sponsor
- Dana-Farber Cancer Institute
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2003
- Completion date
- August 31, 2009
- Enrollment
- 57 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer